180 related articles for article (PubMed ID: 22665013)
1. A case of glioblastoma multiforme with long term survival: can we predict the outcome?
Kumar A; Deopujari C; Karmarkar V
Turk Neurosurg; 2012; 22(3):378-81. PubMed ID: 22665013
[TBL] [Abstract][Full Text] [Related]
2. [Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].
Naydenov E; Tzekov C; Minkin K; Nachev S; Marinov M
Khirurgiia (Sofiia); 2009; (2-3):69-74. PubMed ID: 20506796
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
9. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
10. Gliosarcoma: a rare variant of glioblastoma multiforme.
Rizvi S; Asghar AH; Mehboob J
J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival in malignant glioma. Prognostic factors.
Phuphanich S; Ferrall S; Greenberg H
J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
[TBL] [Abstract][Full Text] [Related]
13. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
16. Pleural metastatic disease from glioblastoma multiforme.
Gotway MB; Conomos PJ; Bremner RM
J Thorac Imaging; 2011 May; 26(2):W54-8. PubMed ID: 20634762
[TBL] [Abstract][Full Text] [Related]
17. A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.
Chaichana K; Parker S; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 May; 112(5):997-1004. PubMed ID: 19817542
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme-report of 267 cases treated at a single institution.
Stark AM; Nabavi A; Mehdorn HM; Blömer U
Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
[TBL] [Abstract][Full Text] [Related]
19. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
[TBL] [Abstract][Full Text] [Related]
20. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
